Avista Corp. (AVA) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts AVA Hot Sheet
Price: $38.53 --0%
Financial Fact:
Total operating expenses: 263.76M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total operating expenses: 263.76M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Avista Corp. (NYSE: AVA) reported Q1 EPS of $0.65, $0.04 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $452.26 million versus the consensus estimate of $496.7 million.
For earnings history and earnings-related data on Avista Corp. (AVA) click here.
For earnings history and earnings-related data on Avista Corp. (AVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Nebius Group (NBIS) PT Raised to $300 at Compass Point
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
